| abstract |
A new hydrogen tartrate salt of (R) -3-N, N-dicyclobutylamino-8-fluoro -3,4-dihydro-2H-1-benzopyran-5-carboxamide, particularly its (2R; 3R) -tartrate, plus particularly the hydrogen monohydrate (2R, 3R) tartrate of (R) -3-N, N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1 benzopyran-5-carboxamide, the processes for the manufacture of said tartrate salt, the use of salt in medicine, the use of tartrate salt in the manufacture of pharmaceutical formulations, and a method of treating CNS disorders by administering tartrate salt to a host in need of such treatment. |